Literature DB >> 17325665

Epstein-Barr virus promotes genomic instability in Burkitt's lymphoma.

S A Kamranvar1, B Gruhne, A Szeles, M G Masucci.   

Abstract

Epstein-Barr virus (EBV) has been implicated in the pathogenesis of human malignancies but the mechanisms of oncogenesis remain largely unknown. Genomic instability and chromosomal aberrations are hallmarks of malignant transformation. We report that EBV carriage promotes genomic instability in Burkitt's lymphoma (BL). Cytogenetic analysis of EBV- and EBV+ BL lines and their sublines derived by EBV conversion or spontaneous loss of the viral genome revealed a significant increase in dicentric chromosomes, chromosome fragments and chromatid gaps in EBV-carrying cells. Expression of EBV latency I was sufficient for this effect, whereas a stronger effect was observed in cells expressing latency III. Telomere analysis by fluorescent in situ hybridization revealed an overall increase of telomere size and prevalence of telomere fusion and double strand-break fusion in dicentric chromosomes from EBV+ cells. Phosphorylated H2AX, a reporter of DNA damage and ongoing repair, was increased in virus-carrying cells in the absence of exogenous stimuli, whereas efficient activation of DNA repair was observed in both EBV+ and EBV- cells following treatment with etoposide. These findings point to induction of telomere dysfunction and DNA damage as important mechanisms for EBV oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17325665     DOI: 10.1038/sj.onc.1210324

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  43 in total

Review 1.  EBV-associated lymphomas in adults.

Authors:  Mark Roschewski; Wyndham H Wilson
Journal:  Best Pract Res Clin Haematol       Date:  2012-02-05       Impact factor: 3.020

2.  Chromosomal variation in lymphoblastoid cell lines.

Authors:  Matthew D Shirley; Joseph D Baugher; Eric L Stevens; Zhenya Tang; Norman Gerry; Christine M Beiswanger; Dorit S Berlin; Jonathan Pevsner
Journal:  Hum Mutat       Date:  2012-04-16       Impact factor: 4.878

3.  Epstein-Barr virus BPLF1 deubiquitinates PCNA and attenuates polymerase η recruitment to DNA damage sites.

Authors:  Christopher B Whitehurst; Cyrus Vaziri; Julia Shackelford; Joseph S Pagano
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

4.  Is the Epstein-Barr virus EBNA-1 protein an oncogen?

Authors:  Thomas F Schulz; Susann Cordes
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-11       Impact factor: 11.205

Review 5.  Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications.

Authors:  Jiezhong Chen
Journal:  World J Virol       Date:  2012-12-12

6.  EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda.

Authors:  Lynnette K Tumwine; Jackson Orem; Patrick Kerchan; Wilson Byarugaba; Stefano A Pileri
Journal:  Infect Agent Cancer       Date:  2010-06-30       Impact factor: 2.965

7.  Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.

Authors:  Robert E White; Ian J Groves; Ernest Turro; Jade Yee; Elisabeth Kremmer; Martin J Allday
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

8.  Human cytomegalovirus UL76 induces chromosome aberrations.

Authors:  Voon-Kwan Siew; Chang-Yih Duh; Shang-Kwei Wang
Journal:  J Biomed Sci       Date:  2009-11-25       Impact factor: 8.410

9.  Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells.

Authors:  Chung-Chun Wu; Ming-Tsan Liu; Yu-Ting Chang; Chih-Yeu Fang; Sheng-Ping Chou; Hsin-Wei Liao; Kuan-Lin Kuo; Shih-Lung Hsu; Yi-Ren Chen; Pei-Wen Wang; Yu-Lian Chen; Hsin-Ying Chuang; Chia-Huei Lee; Ming Chen; Wun-Shaing Wayne Chang; Jen-Yang Chen
Journal:  Nucleic Acids Res       Date:  2009-12-23       Impact factor: 16.971

Review 10.  Lessons learnt from large-scale exon re-sequencing of the X chromosome.

Authors:  F Lucy Raymond; Annabel Whibley; Michael R Stratton; Jozef Gecz
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.